Literature DB >> 10984116

Fetal erythrocyte phospholipid polyunsaturated fatty acids are altered in pregnancy complicated with gestational diabetes mellitus.

V Wijendran1, R B Bendel, S C Couch, E H Philipson, S Cheruku, C J Lammi-Keefe.   

Abstract

Insulin resistance and altered maternal metabolism in gestational diabetes mellitus (GDM) may impair fetal arachidonic acid (AA) and docosahexaenoic acid (DHA) status. The objectives were to test the hypothesis that fetal polyunsaturated fatty acids would be altered with GDM and identify factors related to fetal phospholipid (PL) AA and DHA. Maternal and cord vein erythrocyte PL fatty acids were determined in GDM (n = 13) and healthy pregnant women (controls, n = 12). Cord vein erythrocyte PL AA and DHA concentrations were significantly lower in GDM vs. controls. Maternal blood hemoglobin A1C was inversely correlated to fetal erythrocyte PL DHA and AA in controls and GDM (n = 25). Pregravid body mass index was negatively associated with fetal PL DHA. The data support the hypothesis that there is impairment in fetal accretion of DHA and AA in GDM.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10984116     DOI: 10.1007/s11745-000-0602-2

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  15 in total

1.  CRITERIA FOR THE ORAL GLUCOSE TOLERANCE TEST IN PREGNANCY.

Authors:  J B O'SULLIVAN; C M MAHAN
Journal:  Diabetes       Date:  1964 May-Jun       Impact factor: 9.461

2.  Maternal plasma phospholipid polyunsaturated fatty acids in pregnancy with and without gestational diabetes mellitus: relations with maternal factors.

Authors:  V Wijendran; R B Bendel; S C Couch; E H Philipson; K Thomsen; X Zhang; C J Lammi-Keefe
Journal:  Am J Clin Nutr       Date:  1999-07       Impact factor: 7.045

3.  Placental transfer of essential fatty acids in humans: venous-arterial difference for docosahexaenoic acid in fetal umbilical erythrocytes.

Authors:  M Ruyle; W E Connor; G J Anderson; R I Lowensohn
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

4.  n-6 and n-3 fatty acids during early human development.

Authors:  M A Crawford; W Doyle; P Drury; A Lennon; K Costeloe; M Leighfield
Journal:  J Intern Med Suppl       Date:  1989

5.  Obesity and weight loss alter serum polyunsaturated lipids in humans.

Authors:  S D Phinney; P G Davis; S B Johnson; R T Holman
Journal:  Am J Clin Nutr       Date:  1991-04       Impact factor: 7.045

6.  Arachidonic acid deficiency in streptozotocin-induced diabetes.

Authors:  R T Holman; S B Johnson; J M Gerrard; S M Mauer; S Kupcho-Sandberg; D M Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

7.  Composition of phospholipids and of phospholipid fatty acids and aldehydes in human red cells.

Authors:  J T Dodge; G B Phillips
Journal:  J Lipid Res       Date:  1967-11       Impact factor: 5.922

8.  Alterations in transfer and lipid distribution of arachidonic acid in placentas of diabetic pregnancies.

Authors:  D C Kuhn; M A Crawford; M J Stuart; J J Botti; L M Demers
Journal:  Diabetes       Date:  1990-08       Impact factor: 9.461

9.  Cord blood fatty acid composition in infants and in their mothers during the third trimester.

Authors:  Z Friedman; A Danon; E L Lamberth; W J Mann
Journal:  J Pediatr       Date:  1978-03       Impact factor: 4.406

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  26 in total

Review 1.  Impact of gestational diabetes mellitus in the maternal-to-fetal transport of nutrients.

Authors:  João Ricardo Araújo; Elisa Keating; Fátima Martel
Journal:  Curr Diab Rep       Date:  2015-02       Impact factor: 4.810

2.  Maternal Weight Gain Regulates Omega-3 Fatty Acids in Male, Not Female, Neonates.

Authors:  Perrie F O'Tierney-Ginn; Melanie Gillingham; Jessica Fowler; Elizabeth Brass; Nicole E Marshall; Kent L Thornburg
Journal:  Reprod Sci       Date:  2016-07-28       Impact factor: 3.060

Review 3.  Review: The placenta is a programming agent for cardiovascular disease.

Authors:  K L Thornburg; P F O'Tierney; S Louey
Journal:  Placenta       Date:  2010-02-09       Impact factor: 3.481

4.  Effect of ω-3 supplementation on placental lipid metabolism in overweight and obese women.

Authors:  Virtu Calabuig-Navarro; Michelle Puchowicz; Patricia Glazebrook; Maricela Haghiac; Judi Minium; Patrick Catalano; Sylvie Hauguel deMouzon; Perrie O'Tierney-Ginn
Journal:  Am J Clin Nutr       Date:  2016-04       Impact factor: 7.045

5.  Dietary intake of essential and long-chain polyunsaturated fatty acids in pregnancy.

Authors:  Elizabeth D Loosemore; Michelle P Judge; Carol J Lammi-Keefe
Journal:  Lipids       Date:  2004-05       Impact factor: 1.880

Review 6.  Diabetes mellitus during pregnancy and increased risk of schizophrenia in offspring: a review of the evidence and putative mechanisms.

Authors:  Ryan J Van Lieshout; Lakshmi P Voruganti
Journal:  J Psychiatry Neurosci       Date:  2008-09       Impact factor: 6.186

7.  Type 1 diabetes compromises plasma arachidonic and docosahexaenoic acids in newborn babies.

Authors:  Kebreab Ghebremeskel; Beverley Thomas; Clara Lowy; Yoeju Min; Michael A Crawford
Journal:  Lipids       Date:  2004-04       Impact factor: 1.880

8.  Placental transport in response to altered maternal nutrition.

Authors:  F Gaccioli; S Lager; T L Powell; T Jansson
Journal:  J Dev Orig Health Dis       Date:  2013-04       Impact factor: 2.401

9.  Placental oleic acid uptake is lower in male offspring of obese women.

Authors:  E Brass; E Hanson; P F O'Tierney-Ginn
Journal:  Placenta       Date:  2013-04-17       Impact factor: 3.481

Review 10.  Reduced DHA transfer in diabetic pregnancies: mechanistic basis and long-term neurodevelopmental implications.

Authors:  Michelle P Judge; Sharon G Casavant; Juliana A M Dias; Jacqueline M McGrath
Journal:  Nutr Rev       Date:  2016-05-03       Impact factor: 7.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.